American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra's Orticumab

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Caristo-Diagnostics

More Like This

PR Newswire associated0

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI

PR Newswire associated0

Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

PR Newswire associated0

Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention

PR Newswire associated0

The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation At Least 10 Years in Advance

PR Newswire associated0

New Study: CaRi-Heart® Technology Highly Cost-Effective in the NHS

PR Newswire associated0

AMA Approves CPT Codes for Caristo's AI-Powered Heart Disease Risk Stratification and Prevention Technology

PR Newswire associated0

Surrey Cardiovascular Clinic and Caristo Diagnostics Launch Employee Heart Wellness and Disease Prevention Program for UK Employers

PR Newswire associated0

Venturi Cardiology and Caristo Diagnostics Introduce AI-Enabled Heart Disease Diagnosis and Prevention Technology in North West England